Polycystic ovary syndromeThe Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
Under an Elsevier user license
open archive
Key Words
Polycystic ovary syndrome
hirsutism
menstrual dysfunction
phenotype
criteria
Cited by (0)
R.A. is a consultant for drug development at Proctor & Gamble. E.C. has nothing to disclose. D.D. has nothing to disclose. E.D.-K. has nothing to declare. H.F.E.-M. has nothing to disclose. W.F. has nothing to disclose. O.E.J. has nothing to disclose. R.S.L. is a consultant for Glaxo Smith Kline, Ferring, Quat. Rx, Organon, Serono, and Solvay. R.J.N. has nothing to disclose. A.E.T. is an employee of Novartis. S.F.W. has nothing to disclose.
- ∗
Formerly the Androgen Excess Society.
Copyright © 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.